For additional validation of autophagic modulation, we examined levels of the established inhibitor of autophagy, mTOR, which normally converts metabolic and mitogenic signals into protein synthesis, and is a recognised target in MM therapeutics (Hu et al, 2003). Here, MTOR is linked to Miyoshi myopathy.